125 related articles for article (PubMed ID: 30774013)
1. Cilostazol may improve cognition better than clopidogrel in non-surgical adult patients with ischemic moyamoya disease: subanalysis of a prospective cohort.
Ando S; Tsutsui S; Miyoshi K; Sato S; Yanagihara W; Setta K; Chiba T; Fujiwara S; Kobayashi M; Yoshida K; Kubo Y; Ogasawara K
Neurol Res; 2019 May; 41(5):480-487. PubMed ID: 30774013
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Effects between Clopidogrel and Cilostazol on Cerebral Perfusion in Nonsurgical Adult Patients with Symptomatically Ischemic Moyamoya Disease: Subanalysis of a Prospective Cohort.
Chiba T; Setta K; Shimada Y; Yoshida J; Fujimoto K; Tsutsui S; Yoshida K; Kobayashi M; Kubo Y; Fujiwara S; Terasaki K; Ogasawara K
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3373-3379. PubMed ID: 30174225
[TBL] [Abstract][Full Text] [Related]
3. Two-Year Clinical, Cerebral Hemodynamic, and Cognitive Outcomes of Adult Patients Undergoing Medication Alone for Symptomatically Ischemic Moyamoya Disease Without Cerebral Misery Perfusion: A Prospective Cohort Study.
Miyoshi K; Chida K; Kobayashi M; Kubo Y; Yoshida K; Terasaki K; Ogasawara K
Neurosurgery; 2019 Jun; 84(6):1233-1241. PubMed ID: 29850833
[TBL] [Abstract][Full Text] [Related]
4. Five-Year Outcomes of Medical Management Alone for Adult Patients with Ischemic Moyamoya Disease without Cerebral Misery Perfusion.
Kitakami K; Kubo Y; Yabuki M; Oomori D; Takahashi T; Igarashi S; Fujiwara S; Yoshida K; Kobayashi M; Terasaki K; Ogasawara K
Cerebrovasc Dis; 2022; 51(2):158-164. PubMed ID: 34518462
[TBL] [Abstract][Full Text] [Related]
5. Cilostazol for the management of moyamoya disease: a systematic review of the early evidence, efficacy, safety, and future directions.
Abedi A; Sizdahkhani S; Choi W; Nguyen VN; Rennert RC; Russin JJ
Neurosurg Focus; 2023 Oct; 55(4):E9. PubMed ID: 37778042
[TBL] [Abstract][Full Text] [Related]
6. Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study.
Seo WK; Kim JY; Choi EH; Kim YS; Chung JW; Saver JL; Bang OY; Kim GM
J Am Heart Assoc; 2021 Feb; 10(5):e017701. PubMed ID: 33615836
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Cognitive Changes after Revascularization Surgery in Adult Patients with Ischemic Moyamoya Disease.
Uchida S; Kubo Y; Oomori D; Yabuki M; Kitakami K; Fujiwara S; Yoshida K; Kobayashi M; Terasaki K; Ogasawara K
Cerebrovasc Dis Extra; 2021; 11(3):145-154. PubMed ID: 34808627
[TBL] [Abstract][Full Text] [Related]
8. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial.
Suh JW; Lee SP; Park KW; Lee HY; Kang HJ; Koo BK; Cho YS; Youn TJ; Chae IH; Choi DJ; Rha SW; Bae JH; Kwon TG; Bae JW; Cho MC; Kim HS
J Am Coll Cardiol; 2011 Jan; 57(3):280-9. PubMed ID: 21232664
[TBL] [Abstract][Full Text] [Related]
9. Trends of Antiplatelet Therapy for the Management of Moyamoya Disease in Japan: Results of a Nationwide Survey.
Oki K; Katsumata M; Izawa Y; Takahashi S; Suzuki N; Houkin K;
J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3605-3612. PubMed ID: 30220629
[TBL] [Abstract][Full Text] [Related]
10. Development of cerebral microbleeds and its impact on cognitive function in adult patients receiving medical management alone for ischemic moyamoya disease: supplementary analysis of a 5-year prospective cohort.
Yabuki M; Kubo Y; Kitakami K; Oomori D; Fujiwara S; Yoshida K; Kobayashi M; Ogasawara K
Neurol Res; 2022 Dec; 44(12):1104-1112. PubMed ID: 35975947
[TBL] [Abstract][Full Text] [Related]
11. Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study.
Han Y; Li Y; Wang S; Jing Q; Wang Z; Wang D; Shu Q; Tang X
Am Heart J; 2009 Apr; 157(4):733-9. PubMed ID: 19332203
[TBL] [Abstract][Full Text] [Related]
12. Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis.
Nakagawa I; Wada T; Park HS; Nishimura F; Yamada S; Nakagawa H; Kichikawa K; Nakase H
J Vasc Surg; 2014 Mar; 59(3):761-7. PubMed ID: 24239116
[TBL] [Abstract][Full Text] [Related]
13. Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis.
Taguchi A; Takata Y; Ihara M; Kasahara Y; Tsuji M; Nishino M; Stern D; Okada M
Psychogeriatrics; 2013 Sep; 13(3):164-9. PubMed ID: 25707423
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting.
Nakagawa I; Park HS; Wada T; Yokoyama S; Yamada S; Motoyama Y; Kichikawa K; Nakase H
Neurol Res; 2017 Aug; 39(8):695-701. PubMed ID: 28290236
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Medical Management Alone for Adult Patients with Cerebral Misery Perfusion Due to Ischemic Moyamoya Disease.
Ogasawara K; Uchida S; Akamatsu Y; Chida K; Kobayashi M; Yoshida K; Fujiwara S; Terasaki K; Kubo Y
J Stroke Cerebrovasc Dis; 2022 Aug; 31(8):106588. PubMed ID: 35671656
[TBL] [Abstract][Full Text] [Related]
16. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
Jeong YH; Hwang JY; Kim IS; Park Y; Hwang SJ; Lee SW; Kwak CH; Park SW
Circ Cardiovasc Interv; 2010 Feb; 3(1):17-26. PubMed ID: 20118150
[TBL] [Abstract][Full Text] [Related]
17. Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: a pilot study.
Sakurai H; Hanyu H; Sato T; Kume K; Hirao K; Kanetaka H; Iwamoto T
Geriatr Gerontol Int; 2013 Jan; 13(1):90-7. PubMed ID: 22672107
[TBL] [Abstract][Full Text] [Related]
18. Assessment of cognitive function in adult patients with hemorrhagic moyamoya disease who received no surgical revascularization.
Su SH; Hai J; Zhang L; Yu F; Wu YF
Eur J Neurol; 2013 Jul; 20(7):1081-7. PubMed ID: 23577654
[TBL] [Abstract][Full Text] [Related]
19. Clinical course of asymptomatic adult moyamoya disease.
Jo KI; Yeon JY; Hong SC; Kim JS
Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of adjunctive cilostazol versus high maintenance dose clopidogrel in patients with high post-treatment platelet reactivity: results of the ACCEL-RESISTANCE (Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With Clopidogrel Resistance) randomized study.
Jeong YH; Lee SW; Choi BR; Kim IS; Seo MK; Kwak CH; Hwang JY; Park SW
J Am Coll Cardiol; 2009 Mar; 53(13):1101-9. PubMed ID: 19324253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
